Genomes and Genes

Species

Eva Riveira Munoz

Summary

Affiliation: Hospital Universitari Germans Trias i Pujol
Country: Spain

Publications

  1. Garcia Vidal E, Castellví M, Pujantell M, Badia R, Jou A, Gomez L, et al. Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir. Antimicrob Agents Chemother. 2017;61: pubmed publisher
    ..Stimulation of the RIG-I-dependent interferon (IFN) cascade by acitretin may not significantly affect the selective destruction of latently infected HIV-positive cells. ..
  2. Bray M, Andrei G, Ballana E, Carter K, Durantel D, Gentry B, et al. Meeting report: 31st International Conference on Antiviral Research. Antiviral Res. 2018;158:88-102 pubmed publisher
    ..The 31st ICAR successfully promoted new discoveries in antiviral research and drug development. The 32nd ICAR will be held in Baltimore, Maryland, USA, May 6-10, 2019. ..
  3. Pujantell M, Franco S, Galván Femenía I, Badia R, Castellví M, Garcia Vidal E, et al. ADAR1 affects HCV infection by modulating innate immune response. Antiviral Res. 2018;156:116-127 pubmed publisher
    ..ADAR1 is a potential target to boost antiviral immune response in HCV infection. ..
  4. Badia R, Ballana E, Castellví M, Garcia Vidal E, Pujantell M, Clotet B, et al. CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir. Nat Commun. 2018;9:2739 pubmed publisher
    ..Our results demonstrate that CD32 expression is a marker of CD4+ T cell activation in HIV+ individuals and raises questions regarding the immune resting status of CD32+ cells harboring HIV-1 proviruses. ..
  5. Badia R, Pujantell M, Torres Torronteras J, Menéndez Arias L, Martí R, Ruzo A, et al. SAMHD1 is active in cycling cells permissive to HIV-1 infection. Antiviral Res. 2017;142:123-135 pubmed publisher
    ..Our results demonstrate that SAMHD1 is active in HIV-1 permissive cells, does not modify susceptibility to HIV-1 infection but strongly affects sensitivity to nucleoside inhibitors. ..
  6. Badia R, Ballana E, Esté J, Riveira Muñoz E. Antiviral treatment strategies based on gene silencing and genome editing. Curr Opin Virol. 2017;24:46-54 pubmed publisher
  7. Bassaganyas L, Riveira Munoz E, García Aragonés M, Gonzalez J, Cáceres M, Armengol L, et al. Worldwide population distribution of the common LCE3C-LCE3B deletion associated with psoriasis and other autoimmune disorders. BMC Genomics. 2013;14:261 pubmed publisher